Head and Neck Cancer Trial, Recruiting (NCT04266223)

Head and Neck Cancer Trial, Recruiting NCT04266223 Sponsor: University of Sydney Condition: Head and Neck Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04266223 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Head And Neck Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with head and neck cancer, at any stage
You are 18 years of age or older
You are reasonably active and able to care for yourself, even if you cannot do heavy physical work (confirm with trial site)
You are currently receiving radiation therapy for head and neck cancer using a plastic mask that holds your head still during treatment
You have had any other treatments before this trial
You are willing and able to follow all the requirements of the study
You are able to read and fill out questionnaires written in English

Who may not be able to join:

You have a cognitive impairment that would prevent you from giving informed consent to participate
You are unable to speak or read English, which would make it difficult to go through the consent process

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Purmina Sundaresan, Dr, Western Sydney Local Health District

Phone: +61 2 8627 1133

Australian sites

Blacktown Hospital, Blacktown, New South Wales

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04266223

Sponsor: University of Sydney

Phase: Not Applicable

Status: Recruiting

Condition: Head and Neck Cancer

Trial contact: +61 2 8627 1133

More information: https://clinicaltrials.gov/study/NCT04266223

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with head and neck cancer, at any stage
You are 18 years of age or older
You are reasonably active and able to care for yourself, even if you cannot do heavy physical work (confirm with trial site)
You are currently receiving radiation therapy for head and neck cancer using a plastic mask that holds your head still during treatment
You have had any other treatments before this trial
You are willing and able to follow all the requirements of the study
You are able to read and fill out questionnaires written in English

Who may not be able to join:

You have a cognitive impairment that would prevent you from giving informed consent to participate
You are unable to speak or read English, which would make it difficult to go through the consent process

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Sydney

Registry

ClinicalTrials.gov

Start date

28 March 2023

Est. completion

30 November 2024

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Continuous acquisition of position and motion data of anatomical structures by the surface monitoring system; Patient acceptance of the surface monitoring system

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov